![](/images/graphics-bg.png)
Parallel Changes in Harvey-Bradshaw Index, TNFα, and Intestinal Fatty Acid Binding Protein in Response to Infliximab in Crohn’s Disease
المؤلفون المشاركون
Hellström, Per M.
Al-Saffar, Anas Kh.
Meijer, Carl Hampus
Gannavarapu, Venkata Ram
Hall, Gustav
Li, Yichen
Diaz Tartera, Hetzel O.
Lördal, Mikael
Ljung, Tryggve
Webb, Dominic-Luc
المصدر
Gastroenterology Research and Practice
العدد
المجلد 2017، العدد 2017 (31 ديسمبر/كانون الأول 2017)، ص ص. 1-8، 8ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2017-10-23
دولة النشر
مصر
عدد الصفحات
8
التخصصات الرئيسية
الملخص EN
Intestinal fatty acid binding protein (I-FABP) indicates barrier integrity.
Aims: determine if I-FABP is elevated in active Crohn’s disease (CD) and if I-FABP parallels anti-TNFα antibody (infliximab) induced lowering of TNFα and Harvey-Bradshaw Index (HBI) as potential indicator of mucosal healing.
I-FABP distribution along human gut was determined.
Serum from 10 CD patients collected during first three consecutive infliximab treatments with matched pretreatment and follow-up samples one week after each treatment and corresponding HBI data were analyzed.
I-FABP reference interval was established from 31 healthy subjects with normal gut permeability.
I-FABP and TNFα were measured by ELISA; CRP was measured by nephelometry.
Healthy tissue was used for I-FABP immunohistochemistry.
Pretreatment CD patient TNFα was 1.6-fold higher than in-house reference interval, while I-FABP was 2.5-fold higher, which lowered at follow-ups.
Combining all 30 infusion/follow-up pairs also revealed changes in I-FABP.
HBI followed this pattern; CRP declined gradually.
I-FABP was expressed in epithelium of stomach, jejunum, ileum, and colon, with the highest expression in jejunum and ileum.
I-FABP is elevated in active CD with a magnitude comparable to TNFα.
Parallel infliximab effects on TNFα, HBI, and I-FABP were found.
I-FABP may be useful as an intestine selective prognostic marker in CD.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Al-Saffar, Anas Kh.& Meijer, Carl Hampus& Gannavarapu, Venkata Ram& Hall, Gustav& Li, Yichen& Diaz Tartera, Hetzel O.…[et al.]. 2017. Parallel Changes in Harvey-Bradshaw Index, TNFα, and Intestinal Fatty Acid Binding Protein in Response to Infliximab in Crohn’s Disease. Gastroenterology Research and Practice،Vol. 2017, no. 2017, pp.1-8.
https://search.emarefa.net/detail/BIM-1156182
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Al-Saffar, Anas Kh.…[et al.]. Parallel Changes in Harvey-Bradshaw Index, TNFα, and Intestinal Fatty Acid Binding Protein in Response to Infliximab in Crohn’s Disease. Gastroenterology Research and Practice No. 2017 (2017), pp.1-8.
https://search.emarefa.net/detail/BIM-1156182
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Al-Saffar, Anas Kh.& Meijer, Carl Hampus& Gannavarapu, Venkata Ram& Hall, Gustav& Li, Yichen& Diaz Tartera, Hetzel O.…[et al.]. Parallel Changes in Harvey-Bradshaw Index, TNFα, and Intestinal Fatty Acid Binding Protein in Response to Infliximab in Crohn’s Disease. Gastroenterology Research and Practice. 2017. Vol. 2017, no. 2017, pp.1-8.
https://search.emarefa.net/detail/BIM-1156182
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1156182
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)